Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT, Trimodal), Application (Oncology, Cardiology, Brain, Ophthalmology, Musculoskeletal), End User (Hospitals, Diagnostic Centers, Academia, Pharma-Biotech) - Global Forecast to 2024

マルチモーダルイメージングの世界市場予測:PET-CT、SPECT-CT、PET-MR、OCT、トライモーダル

◆タイトル:Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT, Trimodal), Application (Oncology, Cardiology, Brain, Ophthalmology, Musculoskeletal), End User (Hospitals, Diagnostic Centers, Academia, Pharma-Biotech) - Global Forecast to 2024
◆商品コード:MD 7353
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年9月13日
◆ページ数:142
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、マルチモーダルイメージングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、技術別(PET-CT、SPECT-CT、PET-MR、OCT、トライモーダル)分析、用途別(腫瘍学、循環器、脳、眼科、筋骨格系)分析、エンドユーザー別(病院、診断センター、学界、ファーマバイオテック)分析、マルチモーダルイメージングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、マルチモーダルイメージングの世界市場規模が2019年23億ドルから2024年29億ドルまで年平均4.4%成長すると予測しています。

“The global multimodal imaging market is projected to grow at a CAGR of 4.4% during the forecast period.”Multimodal imaging includes PET/CT systems, SPECT/CT systems, PET/MR systems, OCT/Fundus Imaging systems, and other multimodal imaging systems. The global multimodal imaging market is projected to reach USD 2.9 billion by 2024 from USD 2.3 billion in 2019, at a CAGR of 4.4% from 2019 to 2024.
Growing applications of multimodal imaging systems, technological advancements in diagnostic imaging modalities, availability of funding for research, favorable reimbursement scenario, growing insurance coverage, and increasing R&D into radiotracers are some of the key factors driving the multimodal imaging market. However, the high cost of multimodal imaging systems, lack of infrastructure in emerging countries, and a dearth of trained professionals are expected to limit market growth to a certain extent.

“The PET/CT systems segment accounted for the largest share of the global multimodal imaging market in 2018.”
Based on technology, the multimodal imaging market is broadly segmented into PET/CT systems, PET/MR systems, SPECT/CT systems, OCT/Fundus Imaging systems, and other multimodal imaging systems (tri-modality systems such as SPECT/CT/PET, PET/CT + MR, and IVUS + NIRS systems, among others). The PET/CT systems segment accounted for the largest share of the multimodal imaging market in 2018. This can be attributed to the increasing demand for early and accurate cancer diagnosis, growing clinical evidence for the early detection of Alzheimer’s disease, increasing applications of PET/CT systems in cardiology, favorable reimbursement scenario, and the technological advancements in the field of PET/CT.

“The oncology segment accounted for the largest share of the multimodal imaging market in 2018.”
On the basis of application, the multimodal imaging market is segmented into brain & neurology, cardiology, oncology, ophthalmology, and other applications. The oncology segment accounted for the largest market share in 2018. This can be attributed to the expanding use of multimodal imaging systems in oncology diagnosis, increasing demand for the early & accurate diagnosis of cancer, and growing clinical evidence on the use of multimodal imaging in the diagnosis of novel cancer types.

“Europe accounted for the second-largest share of the global market in 2018.”
The multimodal imaging market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe accounted for the second-largest share of the market in 2018. Factors such as growing product approvals and rising public-private investments for developing multimodal imaging modalities for novel applications are the major factors driving market growth in Europe.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 (30%), Tier 2 (32%), and Tier 3 (38%)
• By Designation: C-level (26%), Director-level (30%), and Others (44%)
• By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)

The major players operating in the multimodal imaging market are GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), United Imaging Healthcare Co., Ltd. (China), Canon Medical Systems Corporation (Japan), Mediso Medical Imaging Kft (Hungary), Neusoft Medical Systems Co., Ltd. (China), Spectrum Dynamics Medical (Switzerland), Infraredx, Inc. (Japan), Topcon Corporation (Japan), Carl Zeiss AG (Germany), and Heidelberg Engineering (Germany).

Research Coverage
This report studies the multimodal imaging market based on technology, application, end user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and the respective countries in these regions.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the multimodal imaging market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 18)
2.1 Secondary and Primary Research Methodology
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions and Limitations
2.4.1 Assumptions for the Study
2.4.2 Limitations
3 Executive Summary (Page No. – 29)
4 Premium Insights (Page No. – 33)
4.1 Multimodal Imaging: Market Overview
4.2 Geographic Analysis: Multimodal Imaging Market Share, By Application and Region, 2018
4.3 Technology Analysis: Market Size, 2019 vs 2024 (USD Million)
4.4 End-User Analysis: Market Share, 2019 vs 2024
4.5 Geographic Snapshot of the Market
5 Market Overview (Page No. – 37)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Applications of Multimodal Imaging Systems
5.2.1.2 Technological Advancements in Diagnostic Imaging Modalities
5.2.1.3 Availability of Funding for Research
5.2.2 Restraints
5.2.2.1 High Cost of Multimodal Imaging Systems
5.2.2.2 Lack of Adequate Healthcare Infrastructure
5.2.3 Opportunities
5.2.3.1 Availability of Reimbursement and Insurance Coverage for Scans
5.2.3.2 Increasing R&D Into Radiotracers
5.2.4 Challenges
5.2.4.1 Dearth of Trained Professionals
6 Multimodal Imaging Market, By Technology (Page No. – 44)
6.1 Introduction
6.2 PET/CT Systems
6.2.1 PET/CT Systems Have Almost Practically Replaced Stand-Alone PET Systems Across the World
6.2.2 PET/CT Systems Market Split By Application, 2017–2024 (USD Million)
6.2.3 PET/CT Systems Market Split By End User, 2017–2024 (USD Million)
6.3 SPECT/CT Systems
6.3.1 Improved Resolution of SPECT/CT Systems has Provided A Clear Advantage Over Stand-Alone Spect Systems
6.3.2 SPECT/CT Systems Market Split By Application, 2017–2024 (USD Million)
6.3.3 SPECT/CT Systems Market Split By End User, 2017–2024 (USD Million)
6.4 PET/MR Systems
6.4.1 PET/MR Systems Showcase Increasing Clinical Evidence With Enhanced Tissue Contrast
6.4.2 PET/MR Systems Market Split By Application, 2017–2024 (USD Million)
6.4.3 PET/MR Systems Market Split By End User, 2017–2024 (USD Million)
6.5 OCT/Fundus Imaging Systems
6.5.1 OCT/Fundus Imaging Systems Have Wide Applications in Retinal Disease Diagnosis
6.5.2 OCT/Fundus Imaging Systems Market Split By Application, 2017–2024 (USD Million)
6.5.3 OCT/Fundus Imaging Systems Market Split By End User, 2017–2024 (USD Million)
6.6 Other Multimodal Imaging Systems
6.6.1 Other Multimodal Imaging Systems Market Split By Application, 2017–2024 (USD Million)
6.6.2 Other Multimodal Imaging Systems Market Split By End User, 2017–2024 (USD Million)
7 Multimodal Imaging Market, By Application (Page No. – 57)
7.1 Introduction
7.2 Oncology
7.2.1 Oncology is the Largest Application Segment of the Market
7.3 Ophthalmology
7.3.1 Technological Innovations in Ophthalmic Multimodal Imaging Systems By Key Market Players to Support Market Growth
7.4 Cardiology
7.4.1 Increasing Prevalence of Cardiac Conditions & Increasing Demand for Early Disease Diagnosis to Support Market Growth
7.5 Brain & Neurology
7.5.1 Increasing Incidence of Brain & Neurological Disorders to Propel the Adoption of Multimodal Imaging Systems
7.6 Other Applications
8 Multimodal Imaging Market, By End User (Page No. – 65)
8.1 Introduction
8.2 Hospitals
8.2.1 Large Hospitals With Nuclear Medicine Departments Have Been Early Adopters of Multimodal Imaging Systems
8.3 Diagnostic Imaging Centers
8.3.1 Increasing Number of Private Imaging Centers is Contributing to the Growth of This Segment
8.4 Other End Users
9 Multimodal Imaging Market, By Region (Page No. – 72)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominates the North American Market
9.2.2 Canada
9.2.2.1 Government Budget Cuts and Long Wait Time for Scans to Hamper the Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Favorable Reimbursement Scenario in the Country to Support Market Growth
9.3.2 UK
9.3.2.1 Government Initiatives and the Increasing Number of Funding and Research Activities Related to the Use of Multimodal Imaging are Driving Market Growth
9.3.3 France
9.3.3.1 France has the Third-Largest Government Expenditure on Healthcare—A Major Factor Driving Market Growth
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Large Installation Base of Hybrid Imaging Systems – A Major Factor Driving Market Growth
9.4.2 China
9.4.2.1 China to Witness the Highest Growth Rate in the Global Market During the Forecast Period
9.4.3 India
9.4.3.1 Lack of Reimbursement for Diagnostic Imaging Procedures to Hamper Market Growth
9.4.4 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.1.1 Brazil Dominates the Latin American Market Due to the High Burden of Cancer
9.5.2 Mexico
9.5.2.1 Rising Incidence of Cancer to Drive Market Growth in Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Improved Healthcare Infrastructure and Growing Awareness of Multimodal Imaging are Driving Market Growth in the Mea
10 Competitive Landscape (Page No. – 101)
10.1 Introduction
10.2 Market Share Analysis, 2018
10.3 Competitive Situation and Trends
10.4 Competitive Leadership Mapping
10.5 Vendor Inclusion Criteria
10.6 Vendor Dive
10.6.1 Visionary Leaders
10.6.2 Innovators
10.6.3 Dynamic Differentiators
10.6.4 Emerging Players
11 Company Profiles (Page No. – 107)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 Canon, Inc.
11.2 GE Healthcare
11.3 Heidelberg Engineering
11.4 Infraredx, Inc. (A Part of Nipro Corporation)
11.5 Koninklijke Philips N.V.
11.6 Mediso Medical Imaging Systems Kft
11.7 Neusoft Medical Systems Co., Ltd
11.8 Siemens Healthineers
11.9 Spectrum Dynamics Medical
11.10 Topcon Corporation
11.11 United Imaging Healthcare Co., Ltd.
11.12 Zeiss Group
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 131)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

List of Tables (69 Tables)
Table 1 Technological Advancements in Multimodal Imaging Systems (2017–2019)
Table 2 Codes for SPECT/CT Fusion Imaging (As of June 2019)
Table 3 National PET, PET/CT, PET/MRi Coverage for Oncology (As of June 2013)
Table 4 Market, By Technology, 2017–2024 (USD Million)
Table 5 PET/CT Systems Market, By Region, 2017–2024 (USD Million)
Table 6 PET/CT Systems Market, By Application, 2017–2024 (USD Million)
Table 7 PET/CT Systems Market, By End User, 2017–2024 (USD Million)
Table 8 SPECT/CT Systems Market, By Region, 2017–2024 (USD Million)
Table 9 SPECT/CT Systems Market, By Application, 2017–2024 (USD Million)
Table 10 SPECT/CT Systems Market, By End User, 2017–2024 (USD Million)
Table 11 PET/MR Systems Market, By Region, 2017–2024 (USD Million)
Table 12 PET/MR Systems Market, By Application, 2017–2024 (USD Million)
Table 13 PET/MR Systems Market, By End User, 2017–2024 (USD Million)
Table 14 OCT/Fundus Imaging Systems Market, By Region, 2017–2024 (USD Million)
Table 15 OCT/Fundus Imaging Systems Market, By Application, 2017–2024 (USD Million)
Table 16 OCT/Fundus Imaging Systems Market, By End User, 2017–2024 (USD Million)
Table 17 Other Multimodal Imaging Systems Market, By Region, 2017–2024 (USD Million)
Table 18 Other Multimodal Imaging Systems Market, By Application, 2017–2024 (USD Million)
Table 19 Other Multimodal Imaging Systems Market, By End User, 2017–2024 (USD Million)
Table 20 Multimodal Imaging Market, By Application, 2017–2024 (USD Million)
Table 21 Market for Oncology Applications, By Region, 2017–2024 (USD Million)
Table 22 Market for Ophthalmology Applications, By Region, 2017–2024 (USD Million)
Table 23 Market for Cardiology Applications, By Region, 2017–2024 (USD Million)
Table 24 Market for Brain and Neurology Applications, By Region, 2017–2024 (USD Million)
Table 25 Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 26 Market, By End User, 2017–2024 (USD Million)
Table 27 Multimodal Imaging Systems Installed in Hospitals
Table 28 Market for Hospitals, By Region, 2017–2024 (USD Million)
Table 29 Multimodal Imaging Systems Installed in Diagnostic Imaging Centers
Table 30 Market for Diagnostic Imaging Centers, By Region, 2017–2024 (USD Million)
Table 31 Multimodal Imaging Systems Installed in Research and Academic Institutes
Table 32 Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 33 Market, By Region, 2017–2024 (USD Million)
Table 34 North America: Multimodal Imaging Market, By Country, 2017–2024 (USD Million)
Table 35 North America: Market, By Technology, 2017–2024 (USD Million)
Table 36 North America: Market, By Application, 2017–2024 (USD Million)
Table 37 North America: Market, By End User, 2017–2024 (USD Million)
Table 38 US: Market, By Technology, 2017–2024 (USD Million)
Table 39 Canada: Market, By Technology, 2017–2024 (USD Million)
Table 40 Europe: Market, By Country, 2017–2024 (USD Million)
Table 41 Europe: Market, By Technology, 2017–2024 (USD Million)
Table 42 Europe: Market, By Application, 2017–2024 (USD Million)
Table 43 Europe: Market, By End User, 2017–2024 (USD Million)
Table 44 Germany: Market, By Technology, 2017–2024 (USD Million)
Table 45 UK: Market, By Technology, 2017–2024 (USD Million)
Table 46 France: Market, By Technology, 2017–2024 (USD Million)
Table 47 Rest of Europe: Market, By Technology, 2017–2024 (USD Million)
Table 48 Asia Pacific: Multimodal Imaging Market, By Country, 2017–2024 (USD Million)
Table 49 Asia Pacific: Market, By Technology, 2017–2024 (USD Million)
Table 50 Asia Pacific: Market, By Application, 2017–2024 (USD Million)
Table 51 Asia Pacific: Market, By End User, 2017–2024 (USD Million)
Table 52 Japan: Market, By Technology, 2017–2024 (USD Million)
Table 53 China: Market, By Technology, 2017–2024 (USD Million)
Table 54 India: Market, By Technology, 2017–2024 (USD Million)
Table 55 Rest of Asia Pacific: Market, By Technology, 2017–2024 (USD Million)
Table 56 Latin America: Market, By Country, 2017–2024 (USD Million)
Table 57 Latin America: Multimodal Imaging Market, By Technology, 2017–2024 (USD Million)
Table 58 Latin America: Market, By Application, 2017–2024 (USD Million)
Table 59 Latin America: Market, By End User, 2017–2024 (USD Million)
Table 60 Brazil: Market, By Technology, 2017–2024 (USD Million)
Table 61 Mexico: Market, By Technology, 2017–2024 (USD Million)
Table 62 Rest of Latin America: Market, By Technology, 2017–2024 (USD Million)
Table 63 Middle East & Africa: Multimodal Imaging Market, By Technology, 2017–2024 (USD Million)
Table 64 Middle East & Africa: Market, By Application, 2017–2024 (USD Million)
Table 65 Middle East & Africa: Market, By End User, 2017–2024 (USD Million)
Table 66 Product Launches, Approvals, and Enhancements
Table 67 Agreements, Partnerships, and Collaborations
Table 68 Expansions
Table 69 Acquisitions

List of Figures (30 Figures)
Figure 1 Multimodal Imaging Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Market Size Estimation: Overall Market
Figure 6 Market: Data Triangulation Methodology
Figure 7 Market, By Technology, 2019 vs. 2024 (USD Million)
Figure 8 Market, By Application, 2019 vs. 2024 (USD Million)
Figure 9 Market Share, By End User, 2019 vs. 2024 (USD Million)
Figure 10 Geographical Snapshot of the Multimodal Imaging Market
Figure 11 Technological Advancements in Multimodal Imaging and Demand for Early Diagnosis are Driving Market Growth
Figure 12 Oncology Segment is Expected to Dominate the Market With the Largest Share of the Market
Figure 13 PET/CT Segment is Expected to Hold the Dominant Market Share During the Forecast Period
Figure 14 Hospitals Segment is Expected to Hold A Dominant Market Share During the Forecast Period
Figure 15 China to Register the Highest CAGR During the Forecast Period
Figure 16 Multimodal Imaging Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 North America: Market Snapshot
Figure 18 Europe: Market Snapshot
Figure 19 Asia Pacific: Market Snapshot
Figure 20 Key Developments in the Market Between 2016 and 2019
Figure 21 Global Imaging Market Share, By Key Player, 2018
Figure 22 Market (Global) Competitive Leadership Mapping, 2018
Figure 23 Canon, Inc.: Company Snapshot
Figure 24 GE Healthcare: Company Snapshot
Figure 25 Nipro Corporation: Company Snapshot
Figure 26 Koninklijke Philips N.V.: Company Snapshot
Figure 27 Neusoft: Company Snapshot
Figure 28 Siemens AG: Company Snapshot
Figure 29 Topcon Corporation: Company Snapshot
Figure 30 Carl Zeiss AG: Company Snapshot

★調査レポート[マルチモーダルイメージングの世界市場予測:PET-CT、SPECT-CT、PET-MR、OCT、トライモーダル] ( Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT, Trimodal), Application (Oncology, Cardiology, Brain, Ophthalmology, Musculoskeletal), End User (Hospitals, Diagnostic Centers, Academia, Pharma-Biotech) - Global Forecast to 2024 / MD 7353) 販売に関する免責事項
[マルチモーダルイメージングの世界市場予測:PET-CT、SPECT-CT、PET-MR、OCT、トライモーダル] ( Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT, Trimodal), Application (Oncology, Cardiology, Brain, Ophthalmology, Musculoskeletal), End User (Hospitals, Diagnostic Centers, Academia, Pharma-Biotech) - Global Forecast to 2024 / MD 7353) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆